Results
1 -
10 of
28N. Vasdev, A. A. Wilson, S. Houle and A. J. Lough.
N-(4-Methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea (AR-A014418), Acta Cryst. (2007). E63, o1653-o1655Â Â Â Â ??-Lipoic Acid Interaction with Dopamine D2 Receptor-Dependent Activation of the Akt/GSK-3?? Signaling Pathway Induced by Antipsychotics: Potential Relevance for the Treatment of Schizophrenia, Journal of Molecular Neuroscience Activation of AKT1/GSK-3??/??-Cateninu2013TRIM11/Survivin Pathway by Novel GSK-3?? Inhibitor Promotes Neuron Cell Survival: Study in Differentiated SH-SY5Y Cells in OGD Model, Molecular Neurobiology Personalized Medicine and Resurrected Hopes for the Management of Alzheimer?s Disease: A Modular Approach Based on GSK-3?? Inhibitors, Personalised Medicine GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: an intrinsic subcellular mechanism for resistance to mTORC1 inhibition, BMC Cancer Decreased apoptosis in polyamine depleted IEC-6 cells depends on Akt-mediated NF-??B activation but not GSK3?? activity, Apoptosis Akt-mediated GSK-3?? inhibition prevents migration of polyamine-depleted intestinal epithelial cells via Rac1, Cellular and Molecular Life Sciences CMLS Journal of NeuroVirology.
Glycogen synthase kinase-3?? (GSK-3??) inhibitors AR-A014418 and B6B3O prevent human immunodeficiency virusu2014mediated neurotoxicity in primary human neurons, Journal of NeuroVirology